RCELAVITA Medical, Inc.
$3.92-21% 1Y
$3.92
$3.2752 weeks$13.35
Latest close: a new 52-week highOct 8, 2026what changed →
RCEL in its own filings
Nothing in RCEL's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
176
Events found in the filings · across 375 filings · the record starts in 2019
- Hard flags
- none
Hard flags
- Most recent filing
- Aug 11, 2026
Most recent filing · Form 8-K
- Record starts
- Aug 15, 2019
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 5, 2026
- Change in certifying accountanthistorical
- 2020-07-06
- Security removed from listing or deregisteredhistorical · usually a matured note or preferred class, not the common shares
- 2020-07-20
- SEC comment-letter activity17 occurrences
- 2026-04-07
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 11, 2026On August 5, 2026, the Company and Stedical Scientific, Inc. (“Stedical”) entered into a Global Amendment of their existing distribution agreement and manufacturing agreement (the “Global Amendment”)Material agreement entered · Form 8-K
- Aug 6, 2026Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven.Earnings release · press release
- Jun 8, 2026As disclosed in a Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on January 13, 2026, AVITA Medical, Inc. (the “Company”) previously entered into a Credit Agreement and Guaranty (the “Credit Agreement”) with Perceptive Credit Holdings V, LP as a lender and the administrative …Material agreement entered · Form 8-K
- Jun 4, 2026AVITA Medical, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) solely by means of remote communication via live webcast on June 3, 2026 (being June 4, 2026 in Australia)Director or officer change · Form 8-K
- May 14, 2026AVITA Medical Reports First Quarter 2026 Financial Results.Earnings release · press release
- May 1, 2026On April 29, 2026, the Board of Directors (the “Board”) of AVITA Medical, Inc (the "Company") appointed Cary Vance as President and Chief Executive Officer ("CEO"), effective April 30, 2026 (the “Effective Date”)Director or officer change · Form 8-K
- Feb 12, 2026AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results.Earnings release · press release
- Jan 13, 2026Credit Agreement and Guaranty On January 13, 2026 (the “Closing Date”), AVITA Medical, Inc. (the “Company”) entered into a Credit Agreement and Guaranty (the “Credit Agreement”) and a Security Agreement (the “Security Agreement”), by and among the Company, as borrower, Avita Medical Americas, LLC, a wholly-owned …Material agreement entered · Form 8-K
- Jan 5, 2026Election of Directors Effective January 1, 2026, the Board of Directors (the “Board”) of AVITA Medical, Inc. (the "Company") appointed Joe Woody to the Board to serve until the Company’s 2026 Annual Meeting of Stockholders.Director or officer change · Form 8-K
- Nov 6, 2025On November 5, 2025, affiliates of OrbiMed Advisors, LLC (the “Lenders”) and AVITA Medical, Inc. (the “Company”) agreed to a sixth amendment (the “Sixth Amendment”) to the credit agreement, dated October 18, 2023, as previously amended (the “Credit Agreement”)Material agreement entered · Form 8-K
- Oct 17, 2025Effective October 16, 2025 (the “Effective Date”), James Corbett departed from his roles as Chief Executive Officer and member of the Board of Directors (the “Board”) of AVITA Medical, Inc. (the “Company”)Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Medical Devices
Ranks #42 of 51 by RyuScore